Anupam Rasayan’s stock surged following its $150 million acquisition of US-based Jayhawk Fine Chemicals. This strategic move grants Anupam a US manufacturing presence, enhancing its global CDMO capabilities and polymer portfolio. The deal, funded through internal accruals and structured equity, is expected to be EPS accretive from day one and significantly boost US export share.
​Anupam Rasayan’s stock surged following its $150 million acquisition of US-based Jayhawk Fine Chemicals. This strategic move grants Anupam a US manufacturing presence, enhancing its global CDMO capabilities and polymer portfolio. The deal, funded through internal accruals and structured equity, is expected to be EPS accretive from day one and significantly boost US export share. by Soban News (international And National News)
